Cargando…
Glucose-regulated protein 78 demonstrates antiviral effects but is more suitable for hepatocellular carcinoma prevention in hepatitis B
BACKGROUND: Hepatitis B virus (HBV) is the leading cause of liver cirrhosis and hepatocellular carcinoma in Asia and Africa. Existing antivirals cannot cure HBV or eliminate risk of hepatocellular carcinoma. Glucose-regulated protein 78 (GRP78) can inhibit HBV replication, but promote virion secreti...
Autores principales: | Zheng, Nai Q., Zheng, Zi H., Xu, Hai X., Huang, Ming X., Peng, Xiao M. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2017
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5390389/ https://www.ncbi.nlm.nih.gov/pubmed/28407787 http://dx.doi.org/10.1186/s12985-017-0747-z |
Ejemplares similares
-
Glucose-regulated Protein 78 Is an Intracellular Antiviral Factor against Hepatitis B Virus
por: Ma, Yan, et al.
Publicado: (2009) -
Glucose-regulated protein 78 is an antiviral against hepatitis A virus replication
por: Jiang, Xia, et al.
Publicado: (2017) -
Autoantibodies against glucose-regulated protein 78 as serological diagnostic biomarkers in hepatocellular carcinoma
por: SHAO, QING, et al.
Publicado: (2012) -
Is amalgam more suitable?
por: Boscarino, A.
Publicado: (2020) -
Expression and release of glucose-regulated protein-78 (GRP78) in multiple myeloma
por: Steiner, Normann, et al.
Publicado: (2017)